featured
Liraglutide in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Twelve-Week Treatment With Liraglutide As Add-On to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blinded Parallel Study
Diabetes Care 2015 Oct 20;[EPub Ahead of Print], CS Frandsen, TF Dejgaard, JJ Holst, HU Andersen, B Thorsteinsson, S MadsbadFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.